The IUPHAR Guide to IMMUNOPHARMACOLOGY ligand list
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
| Ligand name | ID | Synonyms | ||||||
| A | Back to top | |||||||
| 852A |
|
9025 | ||||||
| A286982 |
|
6592 | A 286982, A-286982 | |||||
| A438079 |
|
4118 | A 438079, A-438079 | |||||
| abatacept |
|
|
6891 | BMS-188667, CTLA4-IgG4m, Orencia®, RG-1046, RG-2077 | ||||
| abediterol |
|
9326 | LAS-100977 | |||||
| AbGn-168H |
|
10013 | AbGn-168, neihulizumab | |||||
| abrezekimab |
|
9806 | CDP7766, UCB-4144, UCB4144, VR-942 | |||||
| ABT-737 |
|
|
8320 | ABT 737, ABT737, compound 2 [PMID 17256834] | ||||
| AC430 |
|
9177 | AC-430 | |||||
| acalabrutinib |
|
|
8912 | ACP-196, Calquence®, Example 6 [US20140155385 A1] | ||||
| Ac-SDKP |
|
10060 | goralatide, seraspenide | |||||
| ACT-389949 |
|
9511 | ||||||
| ACTH {Sp: Human} |
|
|
3633 | Acthar®, adrenocorticotropic hormone (1-39), corticotropin | ||||
| acumapimod |
|
9203 | BCT 197, BCT-197, BCT197, compound A [WO2013139809] | |||||
| adalimumab |
|
|
4860 | D2E7, FKB327, Humira® | ||||
| adavivint |
|
9620 | SM0-4690, SM04690 | |||||
| (-)-adrenaline |
|
|
|
479 | adrenalin, Auvi-Q®, Epipen®, l-adrenaline, L-epinephrine, levoepinephrine | |||
| adrenomedullin {Sp: Human} |
|
683 | AM | |||||
| ADU-S100 |
|
10192 | dithio-(Rp,Rp)-[cyclic[A(2',5')pA(3',5')p]], MIW815, ML RR-S2 CDA, S100 | |||||
| AF12198 |
|
4861 | AF 12198, AF-12198 | |||||
| AFM13 |
|
10067 | AFM 13, AFM-13 | |||||
| agatolimod |
|
9843 | CpG 7909, CpG7909, PF 3512676, PF-3512676, ProMune, VaxImmune | |||||
| AH10-7 |
|
9899 | ||||||
| AH6809 |
|
1896 | AH 6809, AH-6809 | |||||
| AL-78898A |
|
9219 | 4(1MeW), POT-4 | |||||
| alcaftadine |
|
|
7587 | Lastacaft®, R-89674 | ||||
| alefacept |
|
|
6787 | Amevive®, BG 9273, BG 9712, BG-9273, BG-9712, Lfa3Tip | ||||
| alemtuzumab |
|
|
6770 | campath 1H, Campath®, campath-1H, Lemtrada® | ||||
| alimemazine |
|
|
7237 | Nedeltran®, trimeprazine | ||||
| alpelisib |
|
|
7955 | BYL 719, BYL-719, NVP-BYL719 | ||||
| 3 alpha-aminocholestane |
|
9564 | 3AC, 3 α-aminocholestane | |||||
| ALT-803 |
|
9615 | ||||||
| alvelestat |
|
6476 | AZD 9668, AZD-9668, AZD9668, KB-105160 | |||||
| AM-461 |
|
10170 | AM461, Compound 1 [WO2011085033] | |||||
| AM-6120 |
|
10119 | AM6120, peptide 41 [PMID: 30346167] | |||||
| amcinonide |
|
|
7060 | CL-34699, Cyclocort® | ||||
| amelubant |
|
8463 | BIIL 284, BIIL-284 | |||||
| AMG319 |
|
|
8917 | AMG 319, AMG-319 | ||||
| AMG820 |
|
9106 | ||||||
| aminopyridine 2 |
|
10051 | ||||||
| amiselimod |
|
9319 | Example 1 [US20090137530], MT-1303, MT1303 | |||||
| amiselimod phosphate |
|
9491 | amiselimod-P | |||||
| amlexanox |
|
|
|
7113 | AA-673, Amlexanox®, Aphthasol®, CHX-3673 | |||
| anakinra |
|
|
6972 | antril, Kineret® | ||||
| anatumomab mafenatox |
|
9947 | 5T4FabV13SEAD227A, ABR 214936, ABR-214936, ABR214936, pMB125, PNU 214936, PNU-214936, PNU214936, TTS-CD2 | |||||
| ancriviroc |
|
804 | SCH 351125, SCH-351125, SCH-C | |||||
| andecaliximab |
|
9510 | GS-5745, GS5745 | |||||
| andrographolide |
|
9675 | ||||||
| anifrolumab |
|
8258 | MDX-1333, MEDI-546 | |||||
| apafant |
|
1860 | WEB 2086 BS, WEB-2086 | |||||
| apilimod |
|
9859 | STA 5326, STA-5326, STA5326 | |||||
| apratastat |
|
6482 | compound 5h [PMID: 16426848], TMI-05, TMI005 | |||||
| apremilast |
|
|
7372 | CC-10004, Otezla® | ||||
| APRIL {Sp: Human} |
|
5068 | A proliferation-inducing ligand, TALL2, TNF- and APOL-related leukocyte expressed ligand 2, TNF-related death ligand 1, TRDL-1, ZTNF2 | |||||
| arformoterol |
|
|
|
7479 | Brovana®, YM-08316 | |||
| ARN19702 |
|
|
10120 | ARN-19702, compound 8 [PMID: 27404798] | ||||
| ARN726 |
|
9178 | ARN-726, compound 6 [PMID: 25874594] | |||||
| (R)-ARN2508 |
|
9000 | compound (-)-10r [PMID: 26774927], example 19 [WO2014023643] | |||||
| (S)-ARN2508 |
|
|
8999 | compound (+)-10r [PMID: 26774927], example 20 [WO2014023643] | ||||
| ARRY-382 |
|
9108 | ARRY 382, ARRY382 | |||||
| ARRY-502 |
|
10179 | ARRY502, example 237, enantiomer 1 [WO2009158426A1] | |||||
| AS101 |
|
437 | ammonium tri-chloro(dioxoethylene-O,O'-)tellurate, AS 101, AS-101 | |||||
| asimadoline |
|
9279 | EMD 61 753, EMD 61753, EMD-61753 | |||||
| asivatrep |
|
9621 | Example 230 [US7858621], PAC-14028 | |||||
| ASN002 |
|
10000 | ||||||
| ASP4058 |
|
9569 | ASP-4058 | |||||
| aspirin |
|
|
|
4139 | Acetophen®, acetylsalicylic acid, Aspirin® | |||
| aspirin-triggered resolvin D1 |
|
6239 | AT-Resolvin D1, AT-RvD1 | |||||
| AT38 |
|
9020 | [3-(aminocarbonyl)furoxan-4-yl]methyl salicylate | |||||
| atacicept |
|
9517 | TACI-Fc, TACI-Ig | |||||
| ATB-346 |
|
9534 | ATB 346 | |||||
| atezolizumab |
|
|
7990 | MPDL3280A, Tecentriq® | ||||
| atracurium |
|
|
9537 | atracurium besilate, atracurium dibesylate, BW 33A, Tracrium® | ||||
| auranofin |
|
|
6306 | Ridaura®, SK&F-39162, SK-39162 | ||||
| avacopan |
|
|
9450 | CCX-168, CCX168 | ||||
| AVE 0991 |
|
5579 | AVE-0991, AVE0991 | |||||
| avelumab |
|
|
8735 | Bavencio®, MSB-0010718C, MSB0010718C | ||||
| AZ13102909 |
|
9577 | AZ909 | |||||
| AZ3451 |
|
|
9560 | |||||
| AZ7188 |
|
9586 | ||||||
| AZ8838 |
|
|
9585 | |||||
| azacitidine |
|
|
|
6796 | 5-AZAC, 5-azacytidine, ladakamycin, U-18496, Vidaza® | |||
| azapro-3 |
|
9221 | ||||||
| azatadine |
|
|
7119 | Optimine®, SCH-10649 | ||||
| azathioprine |
|
|
7120 | Azasan®, BW-57-322, Imuran® | ||||
| AZD1236 |
|
7844 | AZD 1236, AZD-1236 | |||||
| AZD1678 |
|
9679 | AZD-1678, compound 49 [PMID: 28947948] | |||||
| AZD1981 |
|
7680 | AZD 1981, AZD-1981 | |||||
| AZD2098 |
|
9678 | AZD-2098, compound 47 [PMID: 28947948] | |||||
| AZD2423 |
|
7825 | AZD 2423, AZD-2423 | |||||
| AZD4635 |
|
|
9236 | AZD-4635, compound 4g [PMID: 22220592], Example XCII [US20160175314], HTL-1071, HTL1071 | ||||
| AZD5069 |
|
8948 | ||||||
| AZD5672 |
|
7686 | AZD 5672, AZD-5672 | |||||
| AZD6605 |
|
7823 | AZ 11920155, AZ-11920155, AZ11920155, AZD 6605, AZD-6605 | |||||
| AZD6703 |
|
|
7687 | AZ 12012199, AZ-12012199, AZ12012199, AZD 6703, AZD-6703 | ||||
| AZD7594 |
|
9325 | AZ13189620, compound 15m [PMID: 28937774] | |||||
| AZD7986 |
|
9412 | compound 30 | |||||
| AZD8848 |
|
9256 | DSP-3025 | |||||
| AZD9056 |
|
7826 | AZD 9056, AZD-9056 | |||||
| AZD9567 |
|
|
9812 | AZD 9567, AZD-9567, compound 15 [PMID: 29424542], example 1 [WO2016046260A1] | ||||
| azelaic acid |
|
|
|
7484 | Azelex®, Finacea®, ZK-62498 | |||
| AZ11657312 (salt free) |
|
7722 | ||||||
| B | Back to top | |||||||
| bafetinib |
|
|
7906 | INNO-406, Lyn-IN-1, NS-187 | ||||
| BAFF {Sp: Human} |
|
5069 | B cell-activating factor, CD257 antigen, dendritic cell-derived TNF-like molecule | |||||
| balamapimod |
|
9925 | MKI-833, MKI833 | |||||
| bardoxolone |
|
2717 | CDDO, RTA-401 | |||||
| baricitinib |
|
|
|
7792 | INCB-028050, INCB028050, LY-3009104, LY3009104, Olumiant® | |||
| basiliximab |
|
|
6879 | CHI-621, L04AC02, SDZ-CHI-621, Simulect® | ||||
| BAYu9773 |
|
3381 | BAY u9773, BAY-u 9773 | |||||
| beclometasone |
|
|
7059 | beclomethasone, SCH-18020W | ||||
| beclometasone dipropionate |
|
|
5894 | beclomethasone dipropionate, Beconase®, Qnasl®, Vancenase® | ||||
| begelomab |
|
8691 | Begendina&rg; (proprietary name), BT 5/9, SAND 26 | |||||
| belatacept |
|
|
6892 | BMS-224818, LEA29Y, Nulojix® | ||||
| belimumab |
|
|
6887 | Benlysta®, hBlySmAb-1.1, LimphoStat-B, lymphostat-B | ||||
| belnacasan |
|
9035 | VX-765 | |||||
| benralizumab |
|
|
7674 | BIW-8405, Fasenra®, KHK4563, MEDI-563 | ||||
| bentamapimod |
|
9926 | AS-602801, AS602801, PGL-5001, PGL5001 | |||||
| benzodrocortisone |
|
9731 | compound 1 [WO2013071010], hydrocortisone 17-benzoate | |||||
| 3beta-Hydroxy-20(29)-lupene |
|
9028 | Fagarasterol, Lupeol | |||||
| betamethasone |
|
|
7061 | SCH-4831 | ||||
| BGB-3111 |
|
9591 | ||||||
| BGB-A317 |
|
9592 | hu317-1/IgG4mt2, tislelizumab (proposed INN) | |||||
| BI-1935 |
|
9717 | BI 1935, example 3 [WO2007067836] | |||||
| BI-1950 |
|
9719 | ||||||
| BI-2545 |
|
|
9791 | BI2545, compound 19 [PMID: 29259743] | ||||
| BI605906 |
|
9357 | 3-Amino-4-(1,1-difluoro- propyl)-6-(4-methanesulfonyl- piperidin-1-yl)-thieno[2,3- b]pyridine-2-carboxylic acid amide, compound 115 [US20070293533] | |||||
| BI 653048 |
|
9715 | (R)-39, BI 653048 BS H3PO4, BI-653048, BI653048 | |||||
| BI 665915 |
|
9716 | BI-665915, compound 69 [PMID: 25671290] | |||||
| BI-6901 |
|
9714 | BI 6901, BI 6901, BI6901, eut-22 | |||||
| bifikafusp alfa |
|
9756 | Darleukin, L19-IL2, L19IL2 | |||||
| bihelical apoA-I mimetic peptide 5A |
|
9183 | 5A peptide | |||||
| bimekizumab |
|
9411 | CA028_0496, CDP4940, gL7gH9, UCB-4940, UCB4940, Zu-G1 | |||||
| bimosiamose |
|
9049 | compound 15e [PMID: 9544210], TBC 1269, TBC-1269, TBC1269 | |||||
| BIRT 377 |
|
9720 | BIRT-377 | |||||
| blinatumomab |
|
|
7384 | Blincyto®, bscCD19xCD3, MEDI-538, MT-103, MT103 | ||||
| blisibimod |
|
9518 | A-623, AGP3 peptibody, AMG 623, Fc-Agp-3 | |||||
| BLZ945 |
|
8250 | BLZ 945, BLZ-945 | |||||
| BML-281 |
|
9664 | compound 3 [PMID: 18642892] | |||||
| BMS-1001 |
|
10191 | BMS1001, Example 1001 [WO2015160641A2] | |||||
| BMS-1166 |
|
9608 | compound 2c [PMID: 28613862], Example 1166 [WO2015160641A2] | |||||
| BMS-202 |
|
|
9607 | compound 1c [PMID: 28613862], PD1-PDL1 inhibitor 2 | ||||
| BMS-345541 |
|
5669 | BMS 345541, BMS345541 | |||||
| BMS-509744 |
|
9994 | BMS 509744, BMS509744, compound 3 [PMID:16682193] | |||||
| BMS-561392 |
|
6509 | BMS 561392, BMS561392, DPC-333 | |||||
| BMS-582949 |
|
|
7838 | BMS 582949, BMS582949, PS 540446, PS-540446, PS540446 | ||||
| BMS-681 |
|
|
9430 | compound 13d [PMID: 25893046] | ||||
| BMS-817399 |
|
|
9497 | compound 29 [PMID: 25101488] | ||||
| BMS-986142 |
|
|
9857 | BMS986142, compound 14f [PMID: 27583770] | ||||
| BMS-986195 |
|
9869 | BMS986195, Example 223 [US20160115126A1] | |||||
| BMS-986205 |
|
9707 | BMS986205 | |||||
| bosutinib |
|
|
|
5710 | Bosulif®, SK 606, SK-606, SKI 606 | |||
| brazikumab |
|
9293 | AMG 139, AMG-139, MEDI2070 | |||||
| brentuximab vedotin |
|
|
6772 | Adcetris®, anti-CD30 ADC SGN-35, SGN 35 | ||||
| briakinumab |
|
9213 | ABT-874, J-695, J695, Ozespa | |||||
| brimapitide |
|
9101 | AM-111, D-JNKI-1, XG-102 | |||||
| brimonidine |
|
|
520 | Alphagan®, Lumify®, Mirvaso®, UK14,304, UK14304 | ||||
| BRL-15572 |
|
10 | BRL 15572, BRL-15,572, BRL15572 | |||||
| brodalumab |
|
|
7540 | AMG-827, AMG827, Kyntheum®, Lumicef®, Siliq® | ||||
| bromfenac |
|
|
|
7131 | AHR-10282B, Bromday®, Prolensa®, Xibrom® | |||
| BsAb (CD89-CD20) |
|
9833 | ||||||
| BTK inhibitor 4b |
|
10094 | compound 4b [PMID: 30216722] | |||||
| BTP2 |
|
2438 | YM-58483 | |||||
| budesonide |
|
|
7434 | Entocort®, Jorveza®, Pulmicort®, S-1320, Uceris® | ||||
| butyric acid |
|
|
1059 | butanoic acid, butyrate, C4 | ||||
| BX 471 |
|
767 | BX-471, BX-741 | |||||
| BX-795 |
|
|
8006 | BX 795, BX795 | ||||
| C | Back to top | |||||||
| C108297 |
|
9180 | Compound 52 [PMID:18226897] | |||||
| C391 |
|
9570 | compound 5 [PMID: 27994760] | |||||
| C646 |
|
7004 | ||||||
| C5a {Sp: Human} |
|
573 | C5a anaphylatoxin, complement component C5a, human complement protein | |||||
| CA-4948 |
|
10152 | AU-4948, AU4948, CA4948, example 1 [WO2015104688A1] | |||||
| cabiralizumab |
|
9107 | BMS-986227, FPA-008, FPA008 | |||||
| camrelizumab |
|
9758 | INCSHR1210, SHR-1210 | |||||
| canakinumab |
|
|
6773 | ACZ 885, ACZ885, Ilaris® | ||||
| canertinib |
|
5675 | CI 1033, CI-1033, PD 183805 dihydrochloride | |||||
| carprofen |
|
|
7141 | Ro-205720000 | ||||
| CBS-3595 |
|
9610 | ||||||
| CC-885 |
|
9224 | ||||||
| CCL1 {Sp: Human} |
|
812 | I309, TCA-3 | |||||
| CCL11 {Sp: Human} |
|
769 | eotaxin | |||||
| CCL13 {Sp: Human} |
|
770 | monocyte chemotactic protein-4 | |||||
| CCL14 {Sp: Human} |
|
753 | CCL14a, CKβ1, haemofiltrate CC chemokine 1 (HCC-1), HCC-1(1-74) | |||||
| CCL15 {Sp: Human} |
|
754 | Lkn-1 [Leukotactin-1], macrophage inflammatory protein-1δ, MIP-1δ | |||||
| CCL16 {Sp: Human} |
|
1272 | ||||||
| CCL17 {Sp: Human} |
|
797 | TARC, thymus- and activation-regulated chemokine | |||||
| CCL18 {Sp: Human} |
|
4382 | macrophage inflammatory protein 4, small-inducible cytokine A18 | |||||
| CCL19 {Sp: Human} |
|
810 | β-chemokine exodus-3, ck β-11, ckβ11, MIP-3β | |||||
| CCL2 {Sp: Human} |
|
771 | ||||||
| CCL20 {Sp: Human} |
|
808 | LARC, liver and activation-regulated chemokine, macrophage inflammatory protein-3α, MIP-3α | |||||
| CCL21 {Sp: Human} |
|
811 | ckβ9, TCA-4 | |||||
| CCL22 {Sp: Human} |
|
798 | dc/β-ck, macrophage-derived chemokine, STCP1 | |||||
| CCL23 {Sp: Human} |
|
755 | ckβ8-1, myeloid progenitor inhibitor factor-1 | |||||
| CCL24 {Sp: Human} |
|
775 | eotaxin-2 | |||||
| CCL25 {Sp: Human} |
|
817 | ||||||
| CCL26 {Sp: Human} |
|
776 | MIP-4α, PTEC | |||||
| CCL27 {Sp: Human} |
|
3646 | ||||||
| CCL28 {Sp: Human} |
|
3649 | ||||||
| CCL3 {Sp: Human} |
|
756 | macrophage inflammatory protein-1α, MIP-1α | |||||
| CCL4 {Sp: Human} |
|
757 | HC21, macrophage inflammatory protein-1β, MIP-1β | |||||
| CCL5 {Sp: Human} |
|
758 | eosinophil chemotactic cytokine [EoCP], regulated upon activation normal T cell expressed and secreted (RANTES) | |||||
| CCL7 {Sp: Human} |
|
759 | ||||||
| CCL8 {Sp: Human} |
|
772 | monocyte chemotactic protein-2 | |||||
| CCL1 {Sp: Mouse} |
|
4404 | ||||||
| CCL11 {Sp: Mouse} |
|
787 | murine eotaxin | |||||
| CCL12 {Sp: Mouse} |
|
4435 | ||||||
| CCL19 {Sp: Mouse} |
|
4417 | ||||||
| CCL2 {Sp: Mouse} |
|
4406 | ||||||
| CCL20 {Sp: Mouse} |
|
4418 | ||||||
| CCL22 {Sp: Mouse} |
|
4420 | ||||||
| CCL24 {Sp: Mouse} |
|
4421 | ||||||
| CCL25 {Sp: Mouse} |
|
4422 | ||||||
| CCL27 {Sp: Mouse} |
|
4462 | ||||||
| CCL28 {Sp: Mouse} |
|
4463 | ||||||
| CCL3 {Sp: Mouse} |
|
4408 | ||||||
| CCL4 {Sp: Mouse} |
|
4410 | ||||||
| CCL7 {Sp: Mouse} |
|
4413 | ||||||
| CCL8 {Sp: Mouse} |
|
4415 | ||||||
| CCL9 {Sp: Mouse} |
|
4434 | ||||||
| CCL5 {Sp: Mouse, Rat} |
|
4412 | ||||||
| CCL11 {Sp: Rat} |
|
4416 | ||||||
| CCL2 {Sp: Rat} |
|
4407 | ||||||
| CCL20 {Sp: Rat} |
|
4419 | ||||||
| CCL3 {Sp: Rat} |
|
4409 | ||||||
| CCL4 {Sp: Rat} |
|
4411 | ||||||
| CCL7 {Sp: Rat} |
|
4414 | ||||||
| Ccl21a {Sp: Mouse} |
|
8651 | 6Ckine-Ser, Exodus-2 | |||||
| Ccl21b {Sp: Mouse} |
|
8652 | 6Ckine-Leu, Exodus-2 | |||||
| CCR2-RA-[R] |
|
|
9431 | analog 49 (Dasse et al., 2007) | ||||
| CCX354 |
|
10164 | CCX 354, CCX-354, CCX-354-C | |||||
| CDP840 |
|
9330 | CDP 840, CDP-840 | |||||
| celecoxib |
|
|
|
2892 | Celecox®, Onsenal® | |||
| cemiplimab |
|
|
10090 | cemiplimab-rwlc, Libtayo®, REGN-2810, REGN2810, SAR-439684, SAR439684 | ||||
| cenerimod |
|
9824 | ACT-334441 | |||||
| cenicriviroc |
|
801 | TAK 652, TAK-652, TAK652, TBR-652 | |||||
| cerdulatinib |
|
8957 | PRT 062070, PRT-062070, PRT-2070, PRT062070 | |||||
| certolizumab pegol |
|
|
6774 | CDP870, Cimzia®, PHA 738144 | ||||
| cetirizine |
|
|
1222 | Reactine®, Zyrtec® | ||||
| cetrorelix |
|
|
1190 | Cetrotide®, SB-075 | ||||
| CFZ533 |
|
9802 | CFZ-533, iscalimab (proposed INN), NVP-CFZ533, OM11-62MF | |||||
| CG200745 |
|
10055 | CG-2, CG-200745, HDCG-0745 | |||||
| 2'3'-cGAMP |
|
|
9207 | cyclic [G(2',5')pA(3',5')p], cyclic GMP-AMP, Cyclic guanosine monophosphate-adenosine monophosphate | ||||
| CGI1746 |
|
|
8066 | CGI 1746, CGI-1746 | ||||
| CGI560 |
|
9264 | CGI-560 | |||||
| CH-4051 |
|
9844 | Formula (10) [WO2012078708A1] | |||||
| chloroquine |
|
|
|
5535 | Aralen®, chloraquine, Malaquin® | |||
| CHMFL-BTK-11 |
|
9516 | ||||||
| cibinetide |
|
9677 | ARA 290, ARA-290, PH-BSP, PHBSP | |||||
| cicaprost |
|
1917 | ZK 96480, ZK-96480 | |||||
| ciclesonide |
|
|
7469 | Alvesco®, Omnaris®, RPR-251526 | ||||
| ciforadenant |
|
10190 | CPI-444, CPI444, V-81444, V81444 | |||||
| cilomilast |
|
|
7407 | SB-207499 | ||||
| cipemastat |
|
6466 | Ro 28-2653 | |||||
| clazakizumab |
|
9195 | ALD-518, ALD518, BMS-945429 | |||||
| clemastine |
|
|
6063 | HS-592, meclastin, Tavegil®, Tavist® | ||||
| clobenpropit |
|
1223 | VUF 9153, VUF-9153 | |||||
| clobetasol propionate |
|
|
7062 | CCI-4725, Clobex®, Dermovate®, GR 2/925, Temovate® | ||||
| clobetasone |
|
|
9088 | Eumovate® | ||||
| clodronic acid |
|
|
9605 | Bonefos®, Clasteon ®, clodronate, Loron® | ||||
| clofazimine |
|
|
9184 | Lamprene® | ||||
| clopidogrel (active metabolite) |
|
1772 | ||||||
| CM4620 |
|
10087 | CM-4620, compound I [WO2016138472A1] | |||||
| CNX-774 |
|
9266 | ||||||
| complement C3 {Sp: Human} |
|
9414 | ||||||
| complement C5 {Sp: Human} |
|
8712 | ||||||
| compound 48/80 |
|
5531 | ||||||
| compound 3a [Pipionne et al, 2018] |
|
9965 | ||||||
| compound 12a [PMID: 29031075] |
|
9684 | ||||||
| compound 19a [PMID: 26506089] |
|
9842 | ||||||
| compound 5b [PMID: 29457898] |
|
9835 | ||||||
| compound 18c [PMID: 25901531] |
|
9227 | ||||||
| compound 7c [PMID: 22041175] |
|
9931 | ||||||
| compound 8c [PMID: 28760529] |
|
9671 | ||||||
| Compound 9 [doi:10.26434/chemrxiv.7072592.v1] |
|
10083 | ||||||
| compound 17d [PMID: 23099093] |
|
8196 | ||||||
| compound 7d [PMID: 29672049] |
|
9937 | ||||||
| compound 5e [PMID: 28580438] |
|
9712 | ||||||
| compound 20f [PMID: 28520415] |
|
9961 | ||||||
| compound 7f [PMID: 29191554] |
|
|
9794 | example 32 [WO2011078413] | ||||
| compound 7f [PMID: 29283260] |
|
9780 | ||||||
| compound 2g [PMID: 27390066] |
|
9682 | ||||||
| compound 4g [PMID: 2680437] |
|
9198 | ||||||
| compound 8ic [PMID: 19081254] |
|
9478 | CCR4 Antagonist | |||||
| compound III [PMID: 24045148] |
|
9709 | ||||||
| compound II [PMID: 21329883] |
|
9579 | ||||||
| compound 17l [PMID: 26288691] |
|
10035 | ||||||
| compound 29 [Moslin et al., 2017] |
|
9992 | ||||||
| compound 12p [Larson et al., 2017] |
|
9690 | ||||||
| compound 11 [PMID: 29442501] |
|
9819 | ||||||
| compound 12 [PMID: 27448772] |
|
|
9453 | |||||
| compound 15 [PMID: 25411721] |
|
9078 | example 252 [WO2007110237] | |||||
| compound 15 [PMID: 29852070] |
|
9997 | ||||||
| compound 16 [PMID: 26794040] |
|
9223 | ||||||
| compound 17 [PMID: 29741897] |
|
10005 | ||||||
| compound 1 [PMID: 24930776] |
|
9092 | DB36 | |||||
| compound 1 [PMID: 28611375] |
|
9673 | ||||||
| compound 21 [PMID: 22802221] |
|
6918 </ | ||||||